Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Emma Walmsley
Biotech
GSK drops 1 potential 'cure' for hep B, focuses on bepirovirsen
GSK is prioritizing its hepatitis B treatment bepirovirsen as the pharma ends work on another potential functional cure for the infectious disease.
James Waldron
Feb 5, 2025 6:00am
Barron quits GSK to take CEO post at $3B biotech startup
Jan 19, 2022 7:30am
New GlaxoSmithKline keeping old R&D model, says embattled CEO
Jul 29, 2021 7:17am
GSK, under pressure to perform, pens $2.2B deal with Alector
Jul 2, 2021 7:30am
COVID-19 vaccine leaders talk need for speed, partners
May 29, 2020 6:40am
GSK bets on tech to help boost lagging R&D
Jan 21, 2020 7:25am
